Motley Fool Wealth Management LLC Has $14.54 Million Stock Holdings in Waters Co. (NYSE:WAT)

Motley Fool Wealth Management LLC lowered its position in shares of Waters Co. (NYSE:WAT) by 3.1% in the third quarter, HoldingsChannel reports. The fund owned 40,394 shares of the medical instruments supplier’s stock after selling 1,289 shares during the period. Motley Fool Wealth Management LLC’s holdings in Waters were worth $14,538,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in WAT. Itau Unibanco Holding S.A. bought a new position in Waters in the second quarter valued at $33,000. Kennebec Savings Bank acquired a new position in shares of Waters during the 3rd quarter worth about $33,000. Blue Trust Inc. grew its holdings in shares of Waters by 190.2% in the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 78 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Waters in the 3rd quarter valued at about $35,000. Finally, TFC Financial Management Inc. raised its holdings in Waters by 19,900.0% during the second quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after acquiring an additional 199 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Trading Down 0.0 %

Shares of NYSE:WAT opened at $387.00 on Wednesday. The company has a market capitalization of $22.98 billion, a P/E ratio of 36.93, a P/E/G ratio of 7.08 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The business’s 50 day simple moving average is $360.14 and its 200 day simple moving average is $333.41. Waters Co. has a 1 year low of $279.24 and a 1 year high of $395.44.

Waters (NYSE:WAT) last posted its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The business had revenue of $740.30 million during the quarter, compared to the consensus estimate of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. Waters’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.84 earnings per share. On average, research analysts anticipate that Waters Co. will post 11.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on WAT shares. JPMorgan Chase & Co. raised their price target on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Evercore ISI lifted their price objective on shares of Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Cfra set a $389.00 target price on shares of Waters in a report on Thursday, October 17th. Wells Fargo & Company lifted their price target on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, TD Cowen raised their price objective on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $365.85.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.